We are live on
!
Find out more
SEC
Seven Eight Capital Portfolio holdings
AUM
$1.11B
1-Year Est. Return
29.48%
This Fund
S&P 500
This Quarter
Est. Return
+5.45%
1 Year Est. Return
+29.48%
3 Year Est. Return
+13.61%
5 Year Est. Return
+117.69%
10 Year Est. Return
+239.1%
AUM
$819M
AUM Growth
+$123M
(+18%)
Cap. Flow
+$101M
Cap. Flow
% of AUM
12.29%
Top 10 Holdings %
Top 10 Hldgs %
9.75%
Holding
710
New
168
Increased
162
Reduced
95
Closed
285
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ICPT
Intercept Pharmaceuticals, Inc.
ICPT
|
+$9.74M |
| 2 |
McDonald's
MCD
|
+$8.2M |
| 3 |
PARA
Paramount Global Class B
PARA
|
+$8.03M |
| 4 |
AGN
Allergan plc
AGN
|
+$7.37M |
| 5 |
Henry Schein
HSIC
|
+$6.53M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nike
NKE
|
+$7.17M |
| 2 |
Lam Research
LRCX
|
+$6.99M |
| 3 |
Electronic Arts
EA
|
+$6.98M |
| 4 |
MBLY
Mobileye N.V.
MBLY
|
+$6.79M |
| 5 |
Hilton Worldwide
HLT
|
+$6.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.19% |
| 2 | Technology | 15.05% |
| 3 | Consumer Discretionary | 14.44% |
| 4 | Financials | 11.43% |
| 5 | Consumer Staples | 9.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
TransUnion
TRU
$16.2B
| $2.14M | 0.26% |
45,300
+5,200
| +13% | +$238K |
|
127
Bunge Global
BG
$22.8B
| $2.13M | 0.26% |
30,635
+24,400
| +391% | +$1.85M |
|
|
SNI
128
DELISTED
Scripps Networks Interactive, Inc Common Class A
SNI
| $2.12M | 0.26% |
+24,700
| New | +$2.03M |
|
129
Myriad Genetics
MYGN
$502M
| $2.12M | 0.26% |
+58,500
| New | +$1.67M |
|
|
VR
130
DELISTED
Validus Hold Ltd
VR
| $2.11M | 0.26% |
+42,800
| New | +$2.17M |
|
131
Molson Coors Class B
TAP
$7.97B
| $2.1M | 0.26% |
25,700
-42,100
| -62% | -$3.7M |
|
132
Lamb Weston
LW
$7.51B
| $2.09M | 0.25% |
44,500
+7,100
| +19% | +$319K |
|
133
Universal Display
OLED
$3.85B
| $2.09M | 0.25% |
16,200
-1,500
| -8% | -$181K |
|
134
Brink's
BCO
$4.87B
| $2.07M | 0.25% |
24,600
+22,300
| +970% | +$1.7M |
|
135
UnitedHealth
UNH
$389B
| $2.03M | 0.25% |
+10,367
| New | +$2M |
|
136
RenaissanceRe
RNR
$13.9B
| $2.01M | 0.25% |
+14,900
| New | +$2.1M |
|
137
Conduent
CNDT
$251M
| $2.01M | 0.25% |
128,478
+93,600
| +268% | +$1.53M |
|
138
Brunswick
BC
$5.33B
| $1.99M | 0.24% |
35,600
+34,400
| +2,867% | +$1.93M |
|
|
HAPN
139
Happen Inc
HAPN
$2.19B
| $1.97M | 0.24% |
+64,720
| New | +$1.86M |
|
140
SiriusXM
SIRI
$10.7B
| $1.97M | 0.24% |
+35,660
| New | +$1.97M |
|
141
Sprouts Farmers Market
SFM
$7.31B
| $1.97M | 0.24% |
104,697
+96,200
| +1,132% | +$2.13M |
|
142
SS&C Technologies
SSNC
$18.8B
| $1.94M | 0.24% |
48,400
+42,000
| +656% | +$1.62M |
|
143
Papa John's
PZZA
$1.02B
| $1.94M | 0.24% |
+26,500
| New | +$1.99M |
|
|
PE
144
DELISTED
PARSLEY ENERGY INC
PE
| $1.94M | 0.24% |
73,500
+70,800
| +2,622% | +$1.87M |
|
145
Guidewire Software
GWRE
$13.3B
| $1.92M | 0.23% |
+24,600
| New | +$1.8M |
|
|
WUBA
146
DELISTED
58.com Inc
WUBA
| $1.91M | 0.23% |
+30,299
| New | +$1.72M |
|
147
United Natural Foods
UNFI
$3.07B
| $1.91M | 0.23% |
45,900
+19,400
| +73% | +$722K |
|
148
Yelp
YELP
$1.51B
| $1.9M | 0.23% |
+43,952
| New | +$1.7M |
|
|
PRAH
149
DELISTED
PRA Health Sciences, Inc.
PRAH
| $1.9M | 0.23% |
24,900
+13,700
| +122% | +$1.04M |
|
150
Edison International
EIX
$30.7B
| $1.89M | 0.23% |
24,491
+20,000
| +445% | +$1.58M |
|
Similar funds
PP
ECM
GCAC
CAM
D
GFS
FTIS
AIA
Seven Eight Capital's Q3 2017 Portfolio in Review
As of Q3 2017, Seven Eight Capital held 710 positions worth $819M, up 18% from $696M the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.
Seven Eight Capital deployed $101M of net new capital in Q3 2017, opening 168 new positions and adding to 162 existing holdings. Its largest new stake was Intercept Pharmaceuticals, Inc.: 90,387 shares worth $5.25M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 10% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Constellation Brands, an estimated $6.37M trimmed.
- Seven Eight Capital's largest Q3 2017 buy was Intercept Pharmaceuticals, Inc.: 90,387 shares worth $5.25M.
- Seven Eight Capital added most to McDonald's in Q3 2017, an estimated $8.2M increase.
- Seven Eight Capital's biggest Q3 2017 reduction was Constellation Brands, cutting an estimated $6.37M.
- Seven Eight Capital fully exited Nike in Q3 2017, selling an estimated $7.17M.
- Seven Eight Capital's ten largest holdings make up 9.8% of its $819M portfolio in Q3 2017.
- Seven Eight Capital opened 168 new positions and closed 285 in Q3 2017.
- Seven Eight Capital's portfolio value rose 18% quarter-over-quarter to $819M.
Based on Seven Eight Capital's 13F filing for Q3 2017, filed 16 Oct 2017.